FDA Investigator Michael L Casner

Michael L Casner has inspections in 14 countries as of 23 Oct 2023. Michael L Casner has collaborated with a combinined 5352 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
79
Last Inspection Date:
23 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
Italy, India, Germany, Taiwan, China, Philippines, United States of America, United Kingdom of Great Britain and Northern Ireland, France, Spain, Mexico, Canada, Portugal, Singapore
Co-Investigator(s):
Abby E Pelletier, Ademola O Daramola, Akilah K Green, Alan A Rivera, Alan L Truong, Alan P Kurtzberg, Alicia M Mozzachio, Alois P Provost, Amber G Wardwell, Amy C Jordan, Amy N Chen, Anastasia I Offordile, Anastasia M Shields, Andrew M Barlow, Angelica M Hernandez, Anissa M Vargas, Anita R Michael, Anthony J Donato, Audrey Thereset Uy, Azza Talaat, Bijoy Panicker, Brandon J Brookens, Brenda Rivera, Brian D Young, Brooke K Higgins, Bruce C Kovak, Bruce H Mccullough, Bryan L Mcguckin, Carl A Anderson, Carl E Lovrich, Carl Lee, CDR John Mastalski, CDR Rochelle B Young, RPh, MSA, Cedar H Boakye, Charisse K Green, Charles M Edwards, Charles R Bonapace, PhD, Charles R Cote, RIC, Chiang Syin, PhD, Christina K Theodorou, Clarice J Ahn, Claudia Mperez Kasmarski, Colleen M Damon, Craig D Zagata, Cynthia A Palmer, Cynthia L Rakestraw, Daniel J Deciero, Daniel J Lahar, Daniel J Min, David A Oluwo, David J Hafner, Deborah J Parris, Debra I Love, Debra J Bennett, Debra L Pagano, Demitria J Xiradakis, Denise M Digiulio, Dennis Cantellops Paite, Dennis R Hock, Derek S Dealy, Devon Jenkins, Diane T Bargo, Dipesh K Shah, Djamila Harouaka, Doan T Nguyen, PharmD, Dongping Dai, PhD, Donna F Campbell, Donyel M Jones, Douglas C Kovacs, Dr. Carmelo Rosa, Dr. Yubing Tang, Edward D Mcdonald, Edwin Melendez, Elaine E Gilfillan, Emest F Bizjak, Eric L Dong, BS, Erik W Koester, Ernest P Bizjak, Farhana Khan, Felix Maldonado, Frederick Razzaghi, Gayle S Lawson, German Rivera, Giovanni A Vigilante, Gladys B Casper, Gregory E Beichner, Gregson A Joseph, Guerlain Ulysse, Hala L Selby, Helen B Ricalde, Heriberto Negron Rivera, Isabel Y Espinosa, Ivis Lnegron Torres, Jaison J Eapen, James C Illuminati, James C Maclaughlin, James M Mason, James M Odonnell, James Norman, James P Mcevoy, James P Mcreavey, Janet A Rajan, Janet L Bowen, Javier E Santos, Javier O Vega, Jawaid Hamid, Jazmine N Brown, Jean Blackston Hill, Jean Blackstone Hill, Jeen S Min, Jeffrey D Meng, Jeffrey Harrison, Jennifer D Hollstrom, Joan M Cantellops Figueroa, Joanne E King, Joanne Heim, Joanne M Hajoway, Joel D Hustedt, Joey C West, Jogy George, John P Mistler, Johnna L Bleem, Jorge L Guadalupe, Jorge L Lajara, Jose Acruz Gonzalez, Jose Alopez Rubet, Jose R Hernandez, Joseph L Despins, PhD, Joseph S Fanelli, Joseph T Dougherty, Judith A Jones, Judith A Paterson, Julianne C Mccullough, Jullianne C Mccullough, June P Page, Junho Pak, Justin A Boyd, Justine M Corson, Karyn M Campbell, Katherine Szestypalow, Keith A Schwartz, Keith M Reilly, Kendra L Brooks, Kenneth H Williams, Kent C Faul, Kham Phommachanh, King, Kirk A Dymbrowski, Ko U Min, Kristen D Evans, Kristina J Donohue, Kristina Mjoyce Pittman, Kristy A Zielny, Larry K Austin, Laurie B Frazier, LCDR Chad N Thompson, LCDR Debra Emerson, LCDR Margaret E Digennaro, LCDR Susan E Polifko, LCDR William H Bender, Libia M Lugo, Lillian S Wu, Liming Zhang, Linda M Hoover, Linda Thai, Lindsey M Schwierjohann, Lisa B Orr, Lisa M Bellows, LT John M Mastalski, Luella J Rossi, Luis A Dasta, Luis M Burgos Medero, Marcellinus D Dordunoo, Marcelo O Mangalindan, Jr, Marcia D Fields, Marcus A Ray, Marea K Harmon, Margaret Faulkner, Margaret L Bolte, Maria A Reed, Maria Estrella, Marian E Ramirez, Marianela Aponte Cruz, Marilyn Santiago, Marjorie L Davis, Marvin D Jones, Mary E Farbman, PhD, Mary E Storch, Marybet Lopez, Matthew B Casale, Matthew R Noonan, Meisha R Sampson, Meisha Waters, Melissa J Garcia, Michael A Taylor, Michael Gurbarg, Michael R Goga, Michael R Klapal, Michael Rosner, Michele L Forster, PhD, Michelle M Noe, Miguel A Martinez, Miguel A Mortimer, Mindy M Chou, Mra Davism, Mra M Barbosar, Mra Mcculloughj, Mra Narulaa, Muna Algharibeh, Muralidhara B Gavini, PhD, Nadeem I Chaudhry, Natasha A Dezinna, Nebil A Oumer, Nicole E Knowlton, Niketa Patel, Paraluman S Leonin, Parul M Patel, Patrice S Hall, Patrick C Klotzbuecher, Patsy J Domingo, Paul A Bonneau, Paul L Bellamy, Paul Mouris, Paula M Laplant, Peter E Baker, Qin Xu, Rachael O Oyewole, Rachel C Harrington, Raffi B Papazian, Rajan Pragani, Rajiv R Srivastava, Ramon A Hernandez, Raymond L Cheung, Rebecca E Dombrowski, Remache, Renisha M Shaw, Robert B Shibuya, MD, Robert J Maffei, Robert J Martin, Robert M Barbosa, Robert Mo Brien, Roger F Zabinski, Roseline N Boateng, Rumany C Penn, PharmD, Russell J Glapion, Russell K Riley, Saied A Asbagh, Saleem A Akhtar, Sam Pepe, Sandra A Boyd, Sanket N Patel, Saundrea A Munroe, Seema S Singh, Seng Ching Hwang, Sharon K Thoma, PharmD, Simone E Pitts, Sina Shojaee, Sneha S Patel, Sony Mathews, State Agency, Stephanie Mangigian, MS/OSH, RN, Stephen J Koniers, Steven D Kehoe, Steven P Donald, Susan F Laska, MS, Susan M Jackson, Susanna E Ford, Analyst, Susant Hadman, Suzanne M Healy, Tamara L Ely, Tamil Arasu, PhD, Tammy L Chavis, Tammy M Phillips, Teigan M Mule, Tekalign Wondimu, Temar Q Williams, Terri L Dodds, Terry Bridgewater, Thomas E Friel, Thomas J Arista, Tiara Nbrown Crosen, Tiffani D Wilson, Torrance J Slayton, Toyin B Oladimeji, Travis R Hunt, Tricia S Martinez, Truong Xuan Nguyen (Andy), Unnee Ranjan, Vaishali J Patel, Valerie L Whipp, Vilmary Negron Rodriguez, Vlada Matusovsky, Wanda J Torres, Wen Ning Chan (Sally), William A Warnick, William J Leonard, William J Muszynski, Xinyi Hui, Yiyue Zhang (nmi), PhD, Youmin Wang, Yumi J Hiramine, Yvins Dezan, Zhongren Wu

Michael L Casner's Documents

Publish Date Document Type Title
March, 2015 FDA 483 BioSpectra Inc. - Form 483, 2015-03-05
August, 2018 FDA 483 K PATEL PHYTO EXTRACTIONS PRIVATE LIMITED - Form 483, 2018-08-03
November, 2021 FDA 483 National Chemical Laboratories, Inc. - Form 483, 2021-11-04
December, 2016 FDA 483 OrBion Pharmaceuticals Private Limited - Form 483, 2016-12-15
February, 2016 EIR SPI Pharma - EIR, 2016-02-12
June, 2015 EIR SGS Chemical Solutions Laboratories Inc. - EIR, 2015-06-03
April, 2019 EIR AAA Pharmaceutical, Inc. - EIR, 2019-04-03
March, 2023 FDA 483 Squire Laboratories - Form 483, 2023-03-16
May, 2018 FDA 483 Laboratorios Leon Farma SAU - Form 483, 2018-05-25
April, 2015 FDA 483 Polysciences, Inc. - Form 483, 2015-04-29
September, 2014 FDA 483 VersaPharm Incorporated - Form 483, 2014-09-25
August, 2015 EIR Sharp Clinical Services, LLC - EIR, 2015-08-27
November, 2018 FDA 483 Chunghwa Chemical Synthesis & Biotech. Ltd - Form 483, 2018-11-09
July, 2019 FDA 483 Frontida BioPharm, LLC - Form 483, 2019-07-19
July, 2019 EIR Frontida BioPharm, LLC - EIR, 2019-07-19
March, 2015 EIR BioSpectra Inc. - EIR, 2015-03-05
April, 2019 FDA 483 AAA Pharmaceutical, Inc. - Form 483, 2019-04-03
July, 2015 FDA 483 Colep Laupheim GmbH & Co. KG - Form 483, 2015-07-10
February, 2015 FDA 483 Central Admixture Pharmacy Services, Inc. - Form 483, 2015-02-11
January, 2016 FDA 483 NATURA BISSE INTERNATIONAL SA - Form 483, 2016-01-29
November, 2014 FDA 483 Sigmapharm Laboratories, LLC - Form 483, 2014-11-19
August, 2015 FDA 483 Jubilant Cadista Pharmaceuticals Inc. - Form 483, 2015-08-07
April, 2019 FDA 483 Response AAA Pharmaceutical, Inc. - Form 483R, 2019-04-15
June, 2015 FDA 483 SGS Chemical Solutions Laboratories Inc. - Form 483, 2015-06-03
November, 2019 EIR Frontage Laboratories, Inc. - EIR, 2019-11-01
February, 2020 FDA 483 Hetero Drugs Limited - Form 483, 2020-02-14
February, 2020 EIR Hetero Drugs Limited - EIR, 2020-02-14
October, 2023 FDA 483 B & J Group - Form 483, 2023-10-02

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more